Since CD133-positive cells, unlike CD133-negative cells, display more aggressiveness in HCC, our present study aims to generate a new genetic risk model comprised of genes highly correlated with CD133 (CD133(hi)) to gain better insights into the relationship between CD133(hi) molecular markers and the prognosis of patients with HCC. The gene discussed is PROM1; the disease is hepatocellular carcinoma.